Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody - Arslan, F; Smeets, MB; O'Neill, LA (Circulation, 2010)
et al.